May 5, 2022Interpace Biosciences, Inc. • May 10th, 2022 • Surgical & medical instruments & apparatus
Company FiledMay 10th, 2022 Industry
FIRST AMENDMENT TO SUBORDINATION AND INTERCREDITOR AGREEMENTSubordination and Intercreditor Agreement • May 10th, 2022 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledMay 10th, 2022 Company Industry JurisdictionThis First Amendment to Subordination and Intercreditor Agreement (“First Amendment to Subordination Agreement”) is made as of May 5, 2022, by and between Comerica Bank (“Bank”) and the BroadOak Fund V, L.P. (“Creditor”).
ContractInterpace Biosciences, Inc. • May 10th, 2022 • Surgical & medical instruments & apparatus
Company FiledMay 10th, 2022 IndustryTHIS INSTRUMENT AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR UPON RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT.
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT AND CONSENTLoan and Security Agreement and Consent • May 10th, 2022 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledMay 10th, 2022 Company IndustryThis First Amendment to Loan and Security Agreement and Consent (this “Amendment”) is entered into as of May 5, 2022 between INTERPACE BIOSCIENCES, INC., a Delaware corporation (“Parent”), INTERPACE DIAGNOSTICS CORPORATION, a Delaware corporation (“Diagnostics Corporation”), INTERPACE DIAGNOSTICS, LLC, a Delaware limited liability company (“Diagnostics”), and INTERPACE PHARMA SOLUTIONS, INC., a Delaware corporation (“Pharma Solutions” and, together with Parent, Diagnostics Corporation and Diagnostics, the “Borrowers” and each individually a “Borrower”) and BROADOAK FUND V, L.P. (“Lender”).